ArticleDisease markers2022

DLX2 Is a Potential Immune-Related Prognostic Indicator Associated with Remodeling of Tumor Microenvironment in Lung Squamous Cell Carcinoma: An Integrated Bioinformatical Analysis.

Liling Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.